Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies.
K P van RheeS L de VroomR M van HestP D van der LindenS H ToninoE MolendijkR A A MathôtN M A BlijlevensCatherijne A J KnibbeRoger J M BrüggemannS E GeerlingsPublished in: The Journal of antimicrobial chemotherapy (2022)
This study supports oral dosing of ciprofloxacin as Gram-negative infection prophylaxis in haematological patients with mild-to-moderate mucositis capable of oral intake.